Shares of Pfizer fell 1.76% to $38.03 at 15:36 EST on Wednesday, after five successive sessions in a row of losses. The New York Stock Exchange is sliding 0.05% to $14,395.00, following yesterday’s upward trend, This seems, as yet, a somewhat negative trend trading session today.
Pfizer’s last close was $38.71, 13.28% under its 52-week high of $43.08.
News about Pfizer today
Some Pfizer vaccine doses returned after getting too cold to use. According to today’s article on Bloomberg Quint, "Pfizer, the Food and Drug Administration and the Centers for Disease Control and Prevention are all working to determine whether the formula can still be used when it reaches such low temperatures, according to Perna.", "Pfizer did not immediately respond to a request for comment."
Pfizer’s sales growth is a negative 9.7% for the current quarter and a decline by 0.5% for the next. The company’s growth estimates for the present quarter and the next is a negative 9.1% and a negative 8.8%, respectively.
Year-on-year quarterly revenue growth declined by 4.3%, now sitting on 48.65B for the twelve trailing months.
Pfizer’s Stock Top and Bottom Yearly Value
Pfizer’s stock is valued at $38.03 at 15:36 EST, way under its 52-week high of $43.08 and way higher than its 52-week low of $26.45.
Pfizer’s Moving Average
Pfizer’s worth is higher than its 50-day moving average of $37.29 and above its 200-day moving average of $35.20.
Previous days news about Pfizer
FDA nears Pfizer decision; Australia cancels order: virus update. According to Bloomberg Quint on Fri Dec 11, "The FDA said it will “rapidly work toward finalization and issuance” of an emergency use authorization following Thursday’s advisory meeting on Pfizer and BioNTech’s Covid vaccine.", "A New York state panel of public-health advisers approved a Food and Drug Administration committee’s backing for emergency use authorization of the Pfizer Inc. and BioNTech SE vaccine, Governor Andrew Cuomo said on Twitter."
Pfizer vaccine clearance to be sought in Hong Kong after FDA nod. According to Bloomberg Quint on Fri Dec 11, "The development comes as Hong Kong on Friday announced it has struck deals for 15 million doses of shots from Pfizer-BioNTech and Chinese developer Sinovac Biotech Ltd., with the first vaccines to be received next month.", "Fosun has yet to apply for authorization for the Pfizer-BioNTech vaccine’s use in mainland China. "
Pfizer raises quarterly cash dividend to 39 cents a share vs. 38 cents. According to MarketWatch on Fri Dec 11, "Pfizer Inc. said Friday’s its board has raised its quarterly cash dividend to 39 cents a share from 38 cents in the year-earlier period. ", "”It is expected that Viatris will begin paying a quarterly dividend in the second quarter of 2021, at which time Pfizer’s quarterly dividend will be reduced such that the combined dividend dollar amount received by Pfizer shareholders, based upon the combination of continued Pfizer ownership and approximately 0.124079 shares of Viatris which were granted for each Pfizer share in the spin-off, will equate to Pfizer’s dividend amount in effect immediately prior to the initiation of the Viatris dividend,” the company said in a statement. "
FDA aiming for quick authorization of Pfizer covid vaccine. According to Bloomberg Quint on Fri Dec 11, "The FDA has asked Pfizer to conduct surveillance for Bell’s palsy cases in vaccine users in the general public. ", "”That’s something we’re working with Pfizer right now on is the appropriate language for the doctors, is if you have a pre-existing serious allergic reaction to anything in these vaccines or medical allergies, you should exercise caution in getting these vaccines initially,” Azar said on Friday in an interview with Fox Business News."
Pfizer vaccine cleared in U.S., a landmark in Covid-19 fight. According to Bloomberg Quint on Sat Dec 12, "Pfizer’s vaccine, like Moderna’s, uses a new technology called messenger RNA that turns the body’s own cells into vaccine-producing factories to fight the coronavirus. ", "The vaccine showed some protection from symptomatic Covid-19 after one shot, but the FDA is recommending people take both doses to achieve the full 95% effectiveness of the vaccine, particularly given that Pfizer studied a two-dose regimen so it’s not known how long the reduced protection from one shot would last."
Mexico approves Pfizer vaccine for emergency use as covid surges. According to Bloomberg Quint on Sat Dec 12, "Mexico’s health agency Cofepris approved Pfizer’s coronavirus vaccine for emergency use, Deputy Health Minister Hugo Lopez-Gatell said at a press conference Friday night.", "Mexico joins the U.K., Canada and the U.S. as countries that have granted emergency use of the Pfizer vaccine. "
Pfizer says prepared to deliver first doses of Covid-19 vaccine in U.S. immediately. According to Business Insider on Sat Dec 12, "Pfizer and BioNTech said that they are confident in their ability to deliver the vaccine to people in the U.S. Their combined manufacturing network has the potential to supply globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses by the end of 2021.", "Pfizer will have marketing and distribution rights worldwide with the exception of China, Germany, and Turkey."
U.S. CDC committee of independent health experts recommends vaccination with Pfizer and biontech Covid-19 vaccine for persons ages 16 years and older. According to Business Insider on Sat Dec 12, "Pfizer Disclosure Notice", "A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com."
Pfizer May offer shots to trial volunteers who received placebo. According to Bloomberg Quint on Mon Dec 14, "Pfizer’s emergency use application provided data from 37,586 volunteers, the majority of whom were in the U.S., according to the FDA. ", "A go-ahead may allow some 19,000 people who received placebos to get Pfizer’s shot, which is in short supply. "
US Covid-19 vaccinations to begin Monday as CDC recommends Pfizer vaccine. According to Business Insider on Mon Dec 14, "CNN reported that the first freight trucks carrying around 184,275 vials of the vaccine departed Pfizer’s facility in Kalamazoo, Michigan, on Sunday.", "According to Perna, it is expected that 145 sites across all the states will receive vaccine on Monday, another 425 sites on Tuesday, and the final 66 sites on Wednesday in the initial delivery of the Pfizer orders for vaccine."
Pfizer, biontech Covid-19 vaccine candidate study in Germany support safety profile. According to MarketWatch on Mon Dec 14, "Pfizer Inc. and its Germany-based partner BioNTech SE said overall results of a Phase 1/2 study in Germany of its COVID-19 vaccine candidate, BNT162b2, mirrored those from the U.S. study. ", "The study’s result come as the companies’ vaccine is being distributed for use in the U.S. Shares of Pfizer rose 1.5% in premarket trading and BioNTech’s stock gained 0.9%, as futures for the S&P 500 tacked on 0.6%."
Pfizer, biontech report data from German phase 1/2 trial with Covid-19 vaccine candidate. According to Business Insider on Mon Dec 14, "Pfizer Inc. (PFE) and BioNTech SE (BNTX) reported additional data on neutralizing antibody and T cell responses from the phase 1/2 trial with BNT162b2 conducted in Germany. ", "BNT162b2 is an investigational COVID-19 vaccine developed by Pfizer-BioNTech. "